These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29850829)

  • 41. Pharmacological stimulation of serotonin 5-HT1B receptors enhances increases in plasma active glucagon-like peptide-1 levels induced by dipeptidyl peptidase-4 inhibition independently of feeding in mice.
    Nonogaki K; Kaji T
    Diabetes Metab; 2015 Nov; 41(5):425-8. PubMed ID: 26234524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between visceral obesity and plasma fibrinogen in obese children.
    Hafez M; El-Masry S; Musa N; Fathy M; Hassan M; Hassan N; El Husseiny M; Tareef M
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):289-96. PubMed ID: 26565545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.
    Maggio AB; Mueller P; Wacker J; Viallon M; Belli DC; Beghetti M; Farpour-Lambert NJ; McLin VA
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):720-6. PubMed ID: 22157928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO study.
    Philipsen A; Jørgensen ME; Vistisen D; Sandbaek A; Almdal TP; Christiansen JS; Lauritzen T; Witte DR
    PLoS One; 2015; 10(4):e0123062. PubMed ID: 25849815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucagon-like peptide 1 and its association with dipeptidyl peptidase IV in subjects with various degrees of glucose tolerance.
    Ruqaya -; Soomro MS; Waris N; Siddiqui IA; Fawwad A; Basit A
    Pak J Pharm Sci; 2020 Nov; 33(6(Supplementary)):2773-2778. PubMed ID: 33879436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.
    Aulinger BA; Bedorf A; Kutscherauer G; de Heer J; Holst JJ; Göke B; Schirra J
    Diabetes; 2014 Mar; 63(3):1079-92. PubMed ID: 24296715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colonic inflammation induces changes in glucose levels through modulation of incretin system.
    Zatorski H; Salaga M; Zielińska M; Mokrowiecka A; Jacenik D; Krajewska WM; Małecka-Panas E; Fichna J
    Pharmacol Rep; 2021 Dec; 73(6):1670-1679. PubMed ID: 34535873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.
    Zander M; Madsbad S; Deacon CF; Holst JJ
    Diabetologia; 2006 Feb; 49(2):369-74. PubMed ID: 16385384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
    Galloway SD; Craig TP; Cleland SJ
    Amino Acids; 2011 Jul; 41(2):507-15. PubMed ID: 20963457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a single bout of aerobic exercise on short-term low-carbohydrate/high-fat intake-induced postprandial glucose metabolism during an oral glucose tolerance test.
    Numao S; Kawano H; Endo N; Yamada Y; Konishi M; Takahashi M; Sakamoto S
    Metabolism; 2013 Oct; 62(10):1406-15. PubMed ID: 23764436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic features and changes in glucose-induced serum glucagon-like peptide-1 levels in children with hypothalamic obesity.
    Chai-Udom R; Aroonparkmongkol S; Sahakitrungruang T
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):331-337. PubMed ID: 29389666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incretin secretion in humans is under the influence of cannabinoid receptors.
    Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats.
    Freyse EJ; Berg S; Kohnert KD; Heinke P; Salzsieder E
    Biol Chem; 2011 Mar; 392(3):209-15. PubMed ID: 21281062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
    de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
    Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher insulin and glucagon-like peptide-1 (GLP-1) levels in healthy, young South Asians as compared to Caucasians during an oral glucose tolerance test.
    Sleddering MA; Bakker LE; Janssen LG; Meinders AE; Jazet IM
    Metabolism; 2014 Feb; 63(2):226-32. PubMed ID: 24290838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.
    Zheng T; Gao Y; Baskota A; Chen T; Ran X; Tian H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2330-4. PubMed ID: 25029421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.
    Migoya EM; Bergeron R; Miller JL; Snyder RN; Tanen M; Hilliard D; Weiss B; Larson P; Gutierrez M; Jiang G; Liu F; Pryor KA; Yao J; Zhu L; Holst JJ; Deacon C; Herman G; Thornberry N; Amatruda J; Williams-Herman D; Wagner JA; SinhaRoy R
    Clin Pharmacol Ther; 2010 Dec; 88(6):801-8. PubMed ID: 21048706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of Diet and Gender on Plasma DPP4 Activity and GLP-1 in Patients with Metabolic Syndrome: An Experimental Pilot Study.
    Pérez-Durillo FT; Segarra AB; Villarejo AB; Ramírez-Sánchez M; Prieto I
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29958403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?
    Wu T; Thazhath SS; Bound MJ; Jones KL; Horowitz M; Rayner CK
    Diabetes Res Clin Pract; 2014 Oct; 106(1):e3-6. PubMed ID: 25172519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.